父母特征与辅助生殖治疗特征对围产结局的影响
该研究基于荷兰13家IVF诊所2000至2011年的ART周期数据,通过概率链接与荷兰围产登记系统匹配,分析23 671例单胎妊娠。结果显示父母特征和ART治疗特征均独立影响围产结局,其中母亲糖尿病对出生体重影响最大(调整差值283 g,95%CI 228-338),冻胚移植相比鲜胚移植出生体重增加100 g(95%CI 84-117)。
要点
- 父母特征与ART治疗特征均独立影响单胎围产结局,出生体重受影响因素最广。
- 母亲糖尿病与出生体重降低关联最强:调整差值283 g(95%CI 228-338)。
- 冻胚移植相比鲜胚移植出生体重增加100 g(95%CI 84-117)。
核心结论
- 父母特征和ART治疗特征均独立影响单胎妊娠的围产结局,出生体重受最广泛因素影响。
研究设计与样本
- 回顾性队列研究,纳入荷兰13家IVF诊所2000年1月1日至2011年1月1日期间所有ART治疗周期(n=36 683),通过概率数据链接与荷兰围产登记系统匹配,最终分析23 671例单胎妊娠。
主要发现
- 与出生体重降低相关的因素包括母亲高血压疾病、非荷兰裔、未产、不孕持续时间增加、hCG黄体期支持(相比孕酮)、较短胚胎培养时间、获卵数增加和鲜胚移植。
- 母亲糖尿病对出生体重影响最大:调整差值283 g(95%CI 228-338)。
- 冻胚移植相比鲜胚移植对出生体重影响最大:调整差值100 g(95%CI 84-117)。
- 南亚裔母亲早产更常见;经产妇和以男性因素为治疗指征者(相比输卵管因素)早产较少见。
临床怎么用
- 在评估ART子代健康时需同时考虑父母特征和ART治疗特征,以尽可能修正可干预因素。
- 结果支持胚胎对早期环境敏感的假说。
局限性
- 回顾性研究无法证明因果关系。
- 无法校正同一母亲多次分娩的数据。
- 部分变量存在缺失值。
- 父母生活方式和一般健康信息有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Do parental characteristics and treatment with ART affect perinatal outcomes in singleton pregnancies? SUMMARY ANSWER: Both parental and ART treatment characteristics affect perinatal outcomes in singleton pregnancies. WHAT IS KNOWN ALREADY: Previous studies have shown that singleton pregnancies resulting from ART are at risk of preterm birth. ART children are lighter at birth after correction for duration of gestation and at increased risk of congenital abnormalities compared to naturally conceived children. This association is confounded by parental characteristics that are also known to affect perinatal outcomes. It is unclear to which extent parental and ART treatment characteristics independently affect perinatal outcomes. STUDY DESIGN, SIZE, DURATION: All IVF clinics in the Netherlands (n = 13) were requested to provide data on all ART treatment cycles (IVF, ICSI and frozen-thawed embryo transfers (FET)), performed between 1 January 2000, and 1 January 2011, which resulted in a pregnancy. Using probabilistic data-linkage, these data (n = 36 683) were linked to the Dutch Perinatal Registry (Perined), which includes all children born in the Netherlands in the same time period (n = 2 548 977). PARTICIPANTS/MATERIALS, SETTING, METHODS: Analyses were limited to singleton pregnancies that resulted from IVF, ICSI or FET cycles. Multivariable models for linear and logistic regression were fitted including parental characteristics as well as ART treatment characteristics. Analyses were performed separately for fresh cycles and for fresh and FET cycles combined. We assessed the impact on the following perinatal outcomes: birth weight, preterm birth below 37 or 32 weeks of gestation, congenital malformations and perinatal mortality. MAIN RESULTS AND THE ROLE OF CHANCE: The perinatal outcomes of 31 184 out of the 36 683 ART treatment cycles leading to a pregnancy were retrieved through linkage with the Perined (85% linkage). Of those, 23 671 concerned singleton pregnancies resulting from IVF, ICSI or FET. Birth weight was independently associated with both parental and ART treatment characteristics. Characteristics associated with lower birth weight included maternal hypertensive disease, non-Dutch maternal ethnicity, nulliparity, increasing duration of subfertility, hCG for luteal phase support (compared to progesterone), shorter embryo culture duration, increasing number of oocytes retrieved and fresh embryo transfer. The parental characteristic with the greatest effect size on birth weight was maternal diabetes (adjusted difference 283 g, 95% CI 228-338). FET was the ART treatment characteristic with the greatest effect size on birth weight (adjusted difference 100 g, 95% CI 84-117) compared to fresh embryo transfer. Preterm birth was more common among mothers of South-Asian ethnicity. Preterm birth was less common among multiparous women and women with 'male factor' as treatment indication (compared to 'tubal factor'). LIMITATIONS, REASONS FOR CAUTION: Due to the retrospective nature of our study, we cannot prove causality. Further limitations of our study were the inability to adjust for mothers giving birth more than once in our dataset, missing values for several variables and limited information on parental lifestyle and general health. WIDER IMPLICATIONS OF THE FINDINGS: Multiple parental and ART treatment characteristics affect perinatal outcomes, with birth weight being influenced by the widest range of factors. This highlights the importance of assessing both parental and ART treatment characteristics in studies that focus on the health of ART-offspring, with the purpose of modifying these factors where possible. Our results further support the hypothesis that the embryo is sensitive to its early environment. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by Foreest Medical School, Alkmaar, the Netherlands (grants: FIO 1307 and FIO 1505). B.W.M. reports grants from NHMRC and consultancy for ObsEva, Merck KGaA, iGenomics and Guerbet. F.B. reports research support grants from Merck Serono and personal fees from Merck Serono. A.C. reports travel support from Ferring BV. and Theramex BV. and personal fees from UpToDate (Hyperthecosis), all outside the remit of the current work. The remaining authors report no conflict of interests. TRIAL REGISTRATION NUMBER: N/A.
引用
- Pontesilli M, Hof MH, Ravelli ACJ, et al. Effect of parental and ART treatment characteristics on perinatal outcomes. Hum Reprod. 2021. PMID: 33860303. doi:10.1093/humrep/deab008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。